Characterization of Nociceptin/Orphanin FQ-Induced Pain Responses by the Novel Receptor AntagonistN-(4-Amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl) Benzamide Monohydrochloride

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2002-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/jpet.102.036095PMID 12235279
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological profiles of a novel opioid receptor‐like1 (ORL1) receptor antagonist, JTC‐801

  2002influential reference
• Antagonism of ORLI receptor produces an algesic effect in the rat formalin test.

  2001cited by this paper
• Effect of intrathecal nocistatin on the formalin-induced pain in mice versus that of nociceptin/orphanin FQ.

  2000influential reference
• Distribution of nociceptin/orphanin FQ precursor protein and receptor in brain and spinal cord: A study using in situ hybridization and X‐gal histochemistry in receptor‐deficient mice

  2000cited by this paper
• Characterization of nociceptin/orphanin FQ-induced pain responses in conscious mice: neonatal capsaicin treatment and N-methyl-D-aspartate receptor GluRepsilon subunit knockout mice.

  2000cited by this paper
• 4-Aminoquinolines: novel nociceptin antagonists with analgesic activity.

  2000influential reference
• Nociceptin/orphanin FQ in spinal nociceptive mechanisms under normal and pathological conditions.

  2000cited by this paper
• Central roles of nociceptin/orphanin FQ and nocistatin: allodynia as a model of neural plasticity.

  2000influential reference
• Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats.

  1999cited by this paper
• Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397).

  1999influential reference
• Opioid receptor‐like (ORL1) receptor distribution in the rat central nervous system: Comparison of ORL1 receptor mRNA expression with 125I‐[14Tyr]‐orphanin FQ binding

  1999cited by this paper
• Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat

  1999cited by this paper
• A new selective antagonist of the nociceptin receptor

  1998cited by this paper
• Anti‐hyperalgesic and anti‐allodynic effects of intrathecal nociceptin/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation

  1998cited by this paper
• Nocistatin, a peptide that blocks nociceptin action in pain transmission

  1998cited by this paper
• Orphanin‐FQ/nociceptin: Lack of antinociceptive, hyperalgesic or allodynic effects in acute thermal or mechanical tests following intracerebroventricular or intrathecal administration to mice or rats

  1998cited by this paper
• Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems

  1998cited by this paper
• [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 is an agonist of the nociceptin (ORL1) receptor.

  1998cited by this paper
• Naltrexone, but not atropine or yohimbine, antagonizes suppression of formalin-induced spinal sensitization by intrathecal nociceptin.

  1998cited by this paper
• Nociceptin/orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve endings in mice.

  1998cited by this paper
• Distribution of prepro‐nociceptin/ orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems

  1998cited by this paper
• Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, in the rat formalin test.

  1997influential reference
• Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor.

  1997cited by this paper
• Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brain.

  1997cited by this paper
• Pharmacological Characterization of Orphanin FQ / Nociceptin and its Fragments 1

  1997cited by this paper
• Spinal analgesic activity of orphanin FQ/nociceptin and its fragments.

  1997cited by this paper
• Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test

  1997influential reference
• Characterization of nociceptin hyperalgesia and allodynia in conscious mice

  1997influential reference
• Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat.

  1996cited by this paper
• Identification and characterization of an endogenous ligand for opioid receptor homologue ROR-C: its involvement in allodynic response to innocuous stimulus.

  1996cited by this paper
• Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor

  1995influential reference
• Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor

  1995influential reference
• Ethical guidelines for investigations of experimental pain in conscious animals.

  1983influential reference

• Mechanisms of alkaliptosis

  2023cites this paper
• Multisolitons-like patterns in a one-dimensional MARCKS protein cyclic model.

  2023cites this paper
• Nociceptin/orphanin FQ receptor expression in clinical pain disorders and functional effects in cultured neurons

  2016cites this paper
• Intrathecal administration of low‐dose nociceptin/orphanin FQ induces allodynia via c‐Jun N‐terminal kinase and monocyte chemoattractant protein‐1

  2016cites this paper
• Nocistatin: milestone of one decade of research.

  2014cites this paper
• Role of Nociceptin/Orphanin FQ and NOP Receptors in the Response to Acute and Repeated Restraint Stress in Rats

  2012cites this paper
• The ORL-1 receptor system: are there opportunities for antagonists in pain therapy?

  2008cites this paper
• Anti-Inflammatory and antipyretic effects of an ethanolic extract of Palisota hirsuta K. Schum roots

  2008cites this paper
• The orphanin FQ/nociceptin (OFQ/N) system.

  2008cites this paper
• The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential

  2008cites this paper
• Signal pathways coupled to activation of neuronal nitric oxide synthase in the spinal cord by nociceptin/orphanin FQ.

  2007cites this paper
• A synthetic kainoid, (2S,3R,4R)-3-carboxymethyl-4-(phenylthio)pyrrolidine-2-carboxylic acid (PSPA-1) serves as a novel anti-allodynic agent for neuropathic pain.

  2007cites this paper
• Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications.

  2007cites this paper
• [Production of nitric oxide in the spinal cord and pain].

  2006cites this paper
• The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2‐induced allodynia, tactile pain associated with nerve injury

  2006cites this paper
• Involvement of Rho-kinase in inflammatory and neuropathic pain through phosphorylation of myristoylated alanine-rich C-kinase substrate (MARCKS).

  2005cites this paper
• Recent advances towards the discovery of ORL-1 receptor agonists and antagonists

  2005cites this paper
• Small-molecule agonists and antagonists of the opioid receptor-like receptor (ORL1, NOP): Ligand-based analysis of structural factors influencing intrinsic activity at NOP

  2005cites this paper
• Modification of Nociception and Morphine Tolerance by the Selective Opiate Receptor-Like Orphan Receptor Antagonist (–)-cis-1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111)

  2004cites this paper
• Normal sensitivity to acute pain, but increased inflammatory hyperalgesia in mice lacking the nociceptin precursor polypeptide or the nociceptin receptor

  2003cites this paper
• Attenuation of neuropathic pain by the nociceptin/orphanin FQ antagonist JTC‐801 is mediated by inhibition of nitric oxide production

  2003cites this paper
• Spinal delivery of analgesics in experimental models of pain and analgesia.

  2003cites this paper
• Utilizing Functional Genomics to Identify New Pain Treatments

  2003cites this paper
• Endogenous opiates and behavior: 2002.

  2003cites this paper
• Characterization of Nociceptin / Orphanin FQ-Induced Pain Responses by the Novel Receptor Antagonist N-( 4-Amino-2-methylquinolin-6-yl )-2-( 4-ethylphenoxymethyl ) Benzamide

  2002cites this paper
• Assessment of antidepressant and antipyretic impacts of an ethanolic concentrate of Palisota hirsuta K. Schum roots

  year unknowncites this paper